Lavrov said the US resumption of military strikes not only violated the spirit of the memorandum, but also shut the door to a political resolution of the crisis.

China's National Healthcare Security Administration announced 601 drugs passed form review for the 2026 national basic medical insurance, maternity and work-injury drug-list adjustment. For the basic insurance list the NHSA received 800 submissions covering 664 generic names; 601 passed form review — 233 were in-list candidates and 368 off-list candidates — a 91% pass rate. For the commercial health insurance innovative-drug list it received 62 submissions covering 62 generics; 58 passed form review (1 in-list, 57 off-list), a 94% pass rate. The NHSA said form review is an initial eligibility check for expert assessment and does not constitute inclusion in the drug lists.

China's June exports in USD terms rose 27.0% YoY, versus a forecast of 18.2% and May's 19.4%.